PlainHospital

DAVOL INC., SUB. C.R. BARD, INC.

Manufacturer adverse-event records for DAVOL INC., SUB. C.R. BARD, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2004–2025 · heavy-book · typical Death-code · injury-heavy

Injury-mix signature

DAVOL INC., SUB. C.R. BARD, INC. leans injury-heavy in event_type mix

Injury-coded event_type share is 96.8% (injury-heavy tercile) beside 0.65% Death-coded (typical). Volume band: heavy.

What the Injury-mix reading shows for DAVOL INC., SUB. C.R. BARD, INC.

The standout signal for DAVOL INC., SUB. C.R. BARD, INC. is Injury-mix: 96.8% Injury-coded (injury-heavy) beside 0.65% Death-coded, on a heavy-book footprint.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair DAVOL INC., SUB. C.R. BARD, INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 20 device types, led in this extract by Injury at 55,675 (96.8% of event_type total). Peak single-year volume reaches 10,170 reports across 22 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

57,503
Total Reports
373
Event-type Death
55,675
Injury Reports
20
Device Types

Event Types

Injury 55,675 (96.8%)
Malfunction 1,247 (2.2%)
Death 373 (0.6%)
Other 183 (0.3%)
25 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 32,978 (50.2%)
Disability 19,538 (29.8%)
S 4,052 (6.2%)
R 3,705 (5.6%)
Other 2,127 (3.2%)
1,304 (2.0%)
Hospitalization 859 (1.3%)
Life Threatening 332 (0.5%)
Death 309 (0.5%)
L 259 (0.4%)
H 75 (0.1%)
D 67 (0.1%)
O 45 (0.1%)
Congenital Anomaly 1 (0.0%)

Devices (20)

Device Reports
Mesh, Surgical, Polymeric 55,309
Staple, Implantable 698
Surgical Film 491
Mesh, Surgical, Absorbable, Abdominal Hernia 312
Mesh, Surgical 249
Laparoscope, General & Plastic Surgery 118
Lavage, Jet 91
Collagen Surgical Mesh Containing Drugs 62
Agent, Absorbable Hemostatic, Non-Collagen Based 43
Sealant, Polymerizing 29
Agent, Absorbable Hemostatic, Collagen Based 23
Apparatus, Autotransfusion 23
Electrosurgical, Cutting & Coagulation & Accessories 22
Laparoscope, Gynecologic (And Accessories) 6
Arthroscope 2
Evacuator, Gastro-Urology 2
Insufflator, Automatic Carbon-Dioxide For Endoscope 2
Insufflator, Hysteroscopic 2
Mesh, Surgical, Deployment Balloon 2
Mesh, Surgical, Synthetic, Urogynecologic, For Apical Vaginal And Uterine Prolapse, Transabdominally Placed 2

Yearly Trend

04
2004: 88
05
2005: 168
06
2006: 336
07
2007: 873
08
2008: 570
09
2009: 523
10
2010: 574
11
2011: 305
12
2012: 557
13
2013: 633
14
2014: 439
15
2015: 427
16
2016: 586
17
2017: 1,132
18
2018: 4,355
19
2019: 10,170
20
2020: 9,392
21
2021: 8,736
22
2022: 7,338
23
2023: 5,229
24
2024: 4,906
25
2025: 166

Read our methodology - how this data is sourced, computed, and verified.